CohBar’s CEO to Participate in Upcoming BIO Webinar
29. November 2021 09:00 ET
|
CohBar, Inc.
MENLO PARK, Calif., Nov. 29, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar Reports Third Quarter 2021 Financial Results and Provides Business Update
15. November 2021 16:02 ET
|
CohBar, Inc.
Company to host conference call at 5:00 p.m. ET MENLO PARK, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria...
CohBar to Announce 2021 Third Quarter Financial Results and Provide Business Update on November 15, 2021
01. November 2021 09:00 ET
|
CohBar, Inc.
MENLO PARK, Calif., Nov. 01, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar Announces Pricing of $15.0 Million Public Offering of Common Stock and Warrants
28. Oktober 2021 08:45 ET
|
CohBar, Inc.
MENLO PARK, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR) (the “Company”), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic...
CohBar Announces Proposed Public Offering of Common Stock and Warrants
27. Oktober 2021 16:01 ET
|
CohBar, Inc.
MENLO PARK, Calif., Oct. 27, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR) (the “Company”), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic...
CohBar Announces CB4211 Phase 1a/1b Results Selected for Late Breaker Presentation at The Liver Meeting® 2021
13. Oktober 2021 09:00 ET
|
CohBar, Inc.
MENLO PARK, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar to Present at H.C. Wainwright 5th Annual NASH Investor Conference
05. Oktober 2021 09:00 ET
|
CohBar, Inc.
MENLO PARK, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar Appoints Joanne Yun, Ph.D. to Its Board of Directors
15. September 2021 09:00 ET
|
CohBar, Inc.
MENLO PARK, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar Granted U.S. Patent Covering CB4211 Compositions and Use for Treating Nonalcoholic Steatohepatitis (NASH)
08. September 2021 09:00 ET
|
CohBar, Inc.
MENLO PARK, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar to Present at Upcoming Investor Conferences
02. September 2021 16:05 ET
|
CohBar, Inc.
MENLO PARK, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...